Synexa buys Syrinx citing its PK and immunogenicity analysis capacity
Synexa Life Sciences has bought Finland based bioanalysis services firm Syrinx Bioanalytics.
South Africa-based biomarker services firm Synexa described the deal – financial terms of which were not disclosed – as part of a wider growth plan to establish the firm as a leader in the analytics space.
Synexa cited Turku-based Syrinx’s capabilities in bioanalysis - particularly in pharmacokinetic and immunogenicity assessment - as the primary motivation for the acquisition.
It added that the combined group will offer biomarker and bioanalytical services, assay development and validation and clinical execution across all phases to clients in the pharma, biotech and biosimilar sectors.
Syrinx’s laboratory in Finland will join Synexa’s network of facilities in Berlin, London, Cape Town and a newly established facility in Rockville, Maryland.
Synexa CEO Emile Lens said, “Today is a significant milestone as we continue to deliver on our buy and build strategy with the aim of building a global leader in specialist biomarker and bioanalytical services.”
This was echoed by Syrinx CEO Sari Liitti, who said the firms have very similar companies in philosophy.
“They both have laboratory services based on strong scientific expertise and close relationships with customers. The companies complement each other very well, with virtually no overlapping functions.”
Liitti also said the merger would drive further expansion, predicting that “New opportunities will open up for the personnel in the international environment, and we expect that operations in Turku will grow significantly in the next few years.”
Synexa - which is backed by European healthcare sector investor Gilde Healthcare – outlined a growth plan earlier this month, citing acquisitions as a major focus.
The firm also said it planned to establish a network of specialist laboratories in the US, Europe, MEA and Asia, that are GCLP, GLP, GCP and/or GMP accredited and have a coordinated service offering across sites, with capacity availability at relatively short notice.
Image: Stock Photo Secrets